Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1035250
Abstract: Background Hypereosinophilic syndrome (HES) is characterized by persistent elevated blood and/or tissue eosinophil levels and eosinophil-mediated organ damage. Presentation is highly heterogenous; patients may experience symptoms affecting multiple organ systems. Objectives To assess the effects… read more here.
Keywords: symptom burden; hes related; therapy improves; mepolizumab therapy ... See more keywords